Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Unity Biotechnology
AddedFeb 19, 2024
UpdatedJun 18, 2026
Unity Biotechnology

Unity Biotechnology

Public

UNITY Biotechnology, a US firm since 2011, develops treatments for osteoarthritis, eye, and lung diseases.

HQ
South San Francisco, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

UNITY Biotechnology, founded in 2011, is dedicated to developing therapeutics aimed at slowing, halting, or reversing diseases associated with aging. The company's core mission is to alleviate the economic, personal, and societal burdens caused by age-related diseases such as osteoarthritis, ophthalmology, and pulmonary conditions. By focusing on these areas, UNITY aims to improve the quality of life for aging populations and reduce healthcare costs.

Notable figures affiliated with UNITY Biotechnology include prominent scientists and industry leaders who contribute to its innovative approach. The company has garnered significant investment from leading venture capital firms, underscoring its potential impact. Key achievements include advancing several promising therapeutic candidates through clinical trials. UNITY's work has positioned it at the forefront of biotechnology, with the potential to transform the treatment landscape for age-related diseases.

Unity Biotechnology - Similar Companies

United Therapeutics logo

United Therapeutics

Retro Biosciences logo

Retro Biosciences

retro.bio

Harmony Biosciences logo

Harmony Biosciences

AgeX Therapeutics logo

AgeX Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Longeveron logo

Longeveron

longeveron.com

Lung Biotechnology logo

Lung Biotechnology

unither.com

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Juvenescence logo

Juvenescence

juvlabs.com

Brii Biosciences logo

Brii Biosciences

briibio.com

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Gerostate Alpha logo

Gerostate Alpha

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

BioHealthonomics logo

BioHealthonomics

Stealth BioTherapeutics logo

Stealth BioTherapeutics

stealthbt.com

Unity Biotechnology - Quick Facts

Who are Unity Biotechnology's competitors?

Companies similar to Unity Biotechnology include United Therapeutics, Retro Biosciences, Harmony Biosciences and AgeX Therapeutics.

When was Unity Biotechnology founded?

Unity Biotechnology was founded in 2009.

Where is Unity Biotechnology's headquarters located?

Unity Biotechnology's headquarters is located in South San Francisco, CA, US.

When was Unity Biotechnology's last funding round?

Unity Biotechnology's most recent funding round was for $4.3M (USD) in November 2023.

How much has Unity Biotechnology raised to-date?

As of Nov 10, 2023, Unity Biotechnology has raised a total of $294.9M (USD).

How many employees does Unity Biotechnology have?

Unity Biotechnology has 70 employees as of Feb 6, 2024.

Unity Biotechnology - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research